Walmart Sees the Slowest Pace in US Comparable Sales in 6 Years and Offers Cautious Guidance

Prescription Drugs -- Not Broke Consumers -- Caused Walmart's Big Sales Whiff

Walmart (NYSE:WMT) delivered the kind of quarter that should have been an easy win. Revenue rose 5.9% to $187.9 billion, topping Wall Street’s $186.8 billion estimate, and management raised its full-year sales and profit outlook. Yet the stock fell after investors focused on a troubling figure: U.S. comparable sales grew just 2.6%, a rare miss ... Prescription Drugs — Not Broke Consumers — Caused Walmart’s Big Sales Whiff

Walmart sees slowest pace in U.S. comparable sales in 6 years

Walmart’s U.S. e-commerce business, which has become an engine of growth for the retailer, rose 24%, trailing the first-quarter pace of 26%.

Walmart reports rare sales miss as consumers cut spending, shares fall ...

Walmart tumbles after Q2 misses, ranks among most overvalued retailers (XRT:NYSEARCA)

Walmart stock drops after Q2 update as guidance misses and WMT earns an F valuation grade vs peers.

Walmart profits top estimates despite slower US sales growth

Walmart reported US$6.4 billion in profits, down 9.4%, as comparable sales growth eased to 2.6%.

Walmart Posts Sluggish Sales With Slowest US Growth in Six Years

Walmart Inc.’s quarterly sales fell short of expectations, a rare miss that’s likely to stoke concern about the leading big-box retailer decelerating alongside a slow-growing US economy.